Cost of Starting Colorectal Cancer Screening Programs: Results From Five Federally Funded Demonstration Programs

Introduction In 2005, the Centers for Disease Control and Prevention (CDC) started a 3-year colorectal cancer screening demonstration project and funded five programs to explore the feasibility of a colorectal cancer program for the underserved U.S. population. CDC is evaluating the five programs to estimate implementation cost, identify best practices, and determine the most cost-effective approach. The objectives are to calculate start-up costs and estimate funding requirements for widespread implementation of colorectal cancer screening programs. Methods An instrument was developed to collect data on resource use and related costs. Costs were estimated for start-up activities, including program management, database development, creation of partnerships, public education and outreach, quality assurance and professional development, and patient support. Monetary value of in-kind contributions to start-up programs was also estimated. Results Start-up time ranged from 9 to 11 months for the five programs; costs ranged from $60,602 to $337,715. CDC funding and in-kind contributions were key resources for the program start-up activities. The budget category with the largest expenditure was labor, which on average accounted for 67% of start-up costs. The largest cost categories by activities were management (28%), database development (17%), administrative (17%), and quality assurance (12%). Other significant expenditures included public education and outreach (9%) and patient support (8%). Conclusion To our knowledge, no previous reports detail the costs to begin a colorectal cancer screening program for the underserved population. Start-up costs were significant, an important consideration in planning and budgeting. In-kind contributions were also critical in overall program funding. Start-up costs varied by the infrastructure available and the unique design of programs. These findings can inform development of organized colorectal cancer programs.

[1]  M. French,et al.  Training and employment programs in methadone treatment: client needs and desires. , 1992, Journal of substance abuse treatment.

[2]  G. Zarkin,et al.  A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). , 1997, Journal of substance abuse treatment.

[3]  A. Sonnenberg,et al.  Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology , 2000, American Journal of Gastroenterology.

[4]  Graham A. Colditz,et al.  Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.

[5]  Patrick C. Walsh,et al.  American Cancer Society Guidelines for the Early Detection of Cancer , 2002, CA: a cancer journal for clinicians.

[6]  R. Hayward,et al.  Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. , 2001, The American journal of medicine.

[7]  Michael Pignone,et al.  Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[8]  Michael Pignone,et al.  Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. , 2002, Annals of internal medicine.

[9]  M. French,et al.  Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP). , 2003, Drug and alcohol dependence.

[10]  R. Coates,et al.  Patterns and predictors of colorectal cancer test use in the adult U.S. population , 2004, Cancer.

[11]  A Thomas McLellan,et al.  Cost estimation when time and resources are limited: the Brief DATCAP. , 2004, Journal of substance abuse treatment.

[12]  Sujha Subramanian,et al.  Use of Colonoscopy for Colorectal Cancer Screening: Evidence from the 2000 National Health Interview Survey , 2005, Cancer Epidemiology Biomarkers & Prevention.

[13]  L. Seeff,et al.  Development of a Federally Funded Demonstration Colorectal Cancer Screening Program , 2008, Preventing chronic disease.